Buyer pain-language targeted: diagnostic lab report delay WhatsApp follow up, pathology lab report status calls, lab report pickup automation India, sample collection follow-up, DPDP checklist diagnostic lab WhatsApp and diagnostic lab CRM follow-up.
Evidence checklist before buying another lab, CRM or WhatsApp system
1. Report-status queue
Track report type, promised turnaround band, current state, patient/customer question, owner and next update without exposing report values or unnecessary health details.
2. Sample collection callback register
Separate home-collection requests, reschedule calls, phlebotomist assignment, address confirmation and unresolved blockers so the owner can see leakage.
3. WhatsApp pickup boundary
Record which messages are safe status/pickup replies and which require identity check, consent review, lab staff review or doctor handoff.
4. LIS/CRM handoff map
Map where report-ready, partial-report, payment-pending, doctor-review and retest states move between LIS, reception, WhatsApp, email and call logs.
5. DPDP evidence prompts
Keep adviser-reviewed notice, consent, purpose, retention, vendor and access-control questions separate from operational follow-up.
6. Owner dashboard
Show ageing report-status requests, callback owners, sample-collection blockers, complaints and human-review queues before automation promises are made.
Download the synthetic owner-evidence pack
Use the template to review report-delay follow-up without sharing real patient reports, lab exports, WhatsApp chats or production credentials.
Owner-review stop rules
- Do not let automation interpret report values, diagnosis, critical findings, clinical priority or treatment next steps.
- Escalate identity mismatch, wrong-recipient risk, consent uncertainty, abnormal/urgent result handling, complaint, refund/payment dispute and doctor questions.
- Do not request production LIS credentials, WhatsApp exports, report PDFs or patient identifiers for a first-fit review.
Truth boundary
No real diagnostic lab, pathology lab, imaging centre, patient, doctor, report, test result, phone number, WhatsApp chat, LIS export, CRM record, billing record, sample record, testimonial, certification, DPDP compliance proof, ranking, demand, lead, appointment, revenue, savings, ROI, turnaround improvement, medical outcome or automation-performance claim is used or implied. This is a synthetic/readiness asset only and provides no legal, privacy, security, medical, laboratory, clinical, diagnostic, billing, advertising, procurement or compliance advice.
FAQ
Can the first review happen without patient data?
Yes. The first review should use anonymized counts, redacted examples, workflow screenshots without identifiers, role maps and owner-approved categories.
What does this help a lab decide?
Whether the real bottleneck is report-status visibility, callback ownership, WhatsApp boundaries, LIS handoff, staff SOPs, consent evidence or software/tool fit.
DPDP for diagnostic labs · Diagnostic lab automation · Request scoped evidence review · Proof policy · LLMs.txt